Type 2 Diabetes Trial, By Invitation NCT06846138 Sponsor: Pauls Stradins Clinical University Hospital Condition: Type 2 Diabetes
Back to Type 2 Diabetes

Type 2 Diabetes Trial, By Invitation

NCT06846138
By Invitation Not Applicable

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • People who have been clinically diagnosed with Type 2 Diabetes.
  • People whose HbA1c (a blood sugar measurement over time) is between 6.5% and 8.5%.
  • People who have been on a stable dose of diabetes tablets for at least 6 months.
  • People aged 25 to 80 years old.
  • People who have previously not been able to tolerate metformin (a common diabetes medicine), such as those who experienced stomach or digestive side effects from it.
  • People who are willing and able to sign a written consent form agreeing to take part.
  • People who are willing to follow study procedures, including providing stool samples and wearing a continuous glucose monitor (a small device that tracks blood sugar levels).

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People who have Type 1 Diabetes.
  • People who are currently using, or have used in the past 6 months, polyherbal formulations (multi-herb supplement products).
  • People who are pregnant or breastfeeding.
  • People who have severe diabetes complications, such as a serious episode of diabetic ketoacidosis, advanced eye disease caused by diabetes (proliferative retinopathy), or significant kidney disease (confirm with trial site for specific kidney function levels).
  • People who have had a major heart or blood vessel event in the last 6 months, such as a stroke, heart attack, unstable chest pain (unstable angina), or heart failure.
  • People with a serious ongoing illness that could affect participation, such as active cancer or severe autoimmune disease.
  • People who have taken antibiotics within 2 months of enrolling in the study.
  • People who have used probiotic or prebiotic supplements within 1 month of enrolling in the study.
  • People who have serious bowel or digestive conditions, such as inflammatory bowel disease, ongoing unexplained chronic diarrhoea, or a severe infection requiring antibiotic treatment.
  • People who have taken part in another interventional research study within the last 3 months.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 1 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
By Invitation
Phase
Not Applicable
Sponsor
Pauls Stradins Clinical University Hospital
Registry
ClinicalTrials.gov
Start date
1 March 2025
Est. completion
1 December 2026

Where this trial is recruiting

🇱🇻 Latvia

Primary endpoints

Change in Glycemic Control (HbA1c Levels)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 1 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov